Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer
Wei Wang,1 Jinshu Wang,2,3 Xinzhong Zhang,2,3 Gang Liu2,3 1Department of Obstetrics and Gynecology, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Zhengzhou, Henan 450003, People’s Republic of China; 2Department of Center for Clinical Single...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-09-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/serum-circsetdb1-is-a-promising-biomarker-for-predicting-response-to-p-peer-reviewed-article-OTT |